Last update 08 May 2025

HG-205

Overview

Basic Info

Drug Type
CRISPR/Cas9
Synonyms
CRISPR/Cas13X RNA base-editing gene therapy (Cholgene)
Target
OTOF Q829X
Action
modulators
Mechanism
OTOF Q829X modulators
Therapeutic Areas
Nervous System DiseasesOtorhinolaryngologic DiseasesOther Diseases
Active Indication-
Inactive Indication
Hearing Loss, Sensorineural
Originator Organization
HuidaGene Therapeutics Co., Ltd.HuidaGene Therapeutics Co., Ltd.
Active Organization-
Inactive Organization
HuidaGene Therapeutics Co., Ltd.HuidaGene Therapeutics Co., Ltd.
License Organization-
Drug Highest PhaseDiscontinuedEarly Phase 1
First Approval Date-
RegulationRare Pediatric Disease (United States), Orphan Drug (United States)
Login to view timeline

Related

1
Clinical Trials associated with HG-205
NCT06025032
/ WithdrawnEarly Phase 1
An Open-label, Multiple-cohort, Dose-finding, Investigator-initiated Trial to Evaluate the Safety, Tolerability, and Efficacy of HG205 RNA Base-Editing Therapy in Subjects With OTOF-p.Q829X Mutation-associated Hearing Loss
100 Clinical Results associated with HG-205
Login to view more data
100 Translational Medicine associated with HG-205
Login to view more data
100 Patents (Medical) associated with HG-205
Login to view more data
100 Deals associated with HG-205
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Hearing Loss, SensorineuralPhase 1
China
HuidaGene Therapeutics Co., Ltd.HuidaGene Therapeutics Co., Ltd.
30 Mar 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free